Ansari K, Wagh V, Saifi A, Saifi I, Chaurasia S
Cureus. 2023; 15(9):e46046.
PMID: 37900456
PMC: 10611549.
DOI: 10.7759/cureus.46046.
Nevo Y, Ferri L
J Gastrointest Oncol. 2023; 14(4):1933-1948.
PMID: 37720442
PMC: 10502549.
DOI: 10.21037/jgo-22-818.
Montalvan E, Montalvan D, Urrutia S, Rodriguez A, Sandoval H, Sauceda P
Rev Med Hondur. 2022; 85(1):6-10.
PMID: 35959361
PMC: 9364809.
Kawaguchi Y, Akaike H, Shoda K, Furuya S, Hosomura N, Amemiya H
World J Gastrointest Surg. 2021; 13(11):1351-1360.
PMID: 34950425
PMC: 8649569.
DOI: 10.4240/wjgs.v13.i11.1351.
Yin J, Yi J, Yang C, Xu B, Lin J, Hu H
Exp Ther Med. 2021; 21(4):315.
PMID: 33717258
PMC: 7885066.
DOI: 10.3892/etm.2021.9746.
Gastric cancer: Epidemiology, risk factors and prevention strategies.
Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X
Chin J Cancer Res. 2021; 32(6):695-704.
PMID: 33446993
PMC: 7797232.
DOI: 10.21147/j.issn.1000-9604.2020.06.03.
Consensus statement of the Hellenic and Cypriot Gastric Cancer Study Group on the diagnosis, staging and management of gastric cancer.
Douridas G, Fountoulakis A, Souglakos J, Gourtsoyianni S, Vini L, Levidou G
Updates Surg. 2020; 72(1):1-19.
PMID: 32112342
DOI: 10.1007/s13304-020-00723-8.
Epidemiology of gastric cancer and risk factors.
Cavatorta O, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G
Acta Biomed. 2018; 89(8-S):82-87.
PMID: 30561423
PMC: 6502220.
DOI: 10.23750/abm.v89i8-S.7966.
Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population.
Chen G, Xu M, Chen J, Hong L, Lin W, Zhao S
J Immunol Res. 2018; 2018:7132868.
PMID: 29670922
PMC: 5835293.
DOI: 10.1155/2018/7132868.
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
Haag G, Stocker G, Quidde J, Jaeger D, Lordick F
BMC Cancer. 2017; 17(1):509.
PMID: 28760152
PMC: 5537937.
DOI: 10.1186/s12885-017-3497-9.
Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.
Zhang Y, Wang H, Bi C, Xiao Y, Liu Z
Oncotarget. 2016; 7(34):54973-54982.
PMID: 27384681
PMC: 5342395.
DOI: 10.18632/oncotarget.10362.
Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy.
Yang K, Lu Z, Zhang W, Liu K, Chen X, Chen X
Medicine (Baltimore). 2015; 94(33):e1305.
PMID: 26287413
PMC: 4616434.
DOI: 10.1097/MD.0000000000001305.
Intrathoracic esophagojejunostomy using OrVil™ for gastric adenocarcinoma involving the esophagus.
Yajima K, Kanda T, Kosugi S, Kano Y, Ishikawa T, Ichikawa H
World J Gastrointest Surg. 2014; 6(12):235-40.
PMID: 25548608
PMC: 4278145.
DOI: 10.4240/wjgs.v6.i12.235.
Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy.
Yang K, Zhang W, Chen X, Chen X, Zhang B, Chen Z
Medicine (Baltimore). 2014; 93(25):e158.
PMID: 25437029
PMC: 4616371.
DOI: 10.1097/MD.0000000000000158.
MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2.
Feng X, Wang Y, Ma Z, Yang R, Liang S, Zhang M
BMC Cancer. 2014; 14:633.
PMID: 25174799
PMC: 4161885.
DOI: 10.1186/1471-2407-14-633.
Gastric cancer: prevention, risk factors and treatment.
Zali H, Rezaei-Tavirani M, Azodi M
Gastroenterol Hepatol Bed Bench. 2014; 4(4):175-85.
PMID: 24834180
PMC: 4017429.
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.
Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F
Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13.
PMID: 24618998
PMC: 4019373.
DOI: 10.1158/1055-9965.EPI-13-1057.
Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites.
Fang N, Zhang H, He B, Xie M, Lu S, Wan Y
Tumour Biol. 2013; 35(4):3261-8.
PMID: 24282088
DOI: 10.1007/s13277-013-1426-3.
Critical role of spatial interaction between CD8⁺ and Foxp3⁺ cells in human gastric cancer: the distance matters.
Feichtenbeiner A, Haas M, Buttner M, Grabenbauer G, Fietkau R, Distel L
Cancer Immunol Immunother. 2013; 63(2):111-9.
PMID: 24170095
PMC: 11029441.
DOI: 10.1007/s00262-013-1491-x.
Clinicopathological features and outcomes of patients with gastric cancer: a single-center experience.
Selcukbiricik F, Buyukunal E, Tural D, Ozguroglu M, Demirelli F, Serdengecti S
World J Gastroenterol. 2013; 19(14):2154-61.
PMID: 23599641
PMC: 3627879.
DOI: 10.3748/wjg.v19.i14.2154.